BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29408352)

  • 1. Promise and challenges for direct small molecule AMPK activators.
    Olivier S; Foretz M; Viollet B
    Biochem Pharmacol; 2018 Jul; 153():147-158. PubMed ID: 29408352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting AMPK: From Ancient Drugs to New Small-Molecule Activators.
    Guigas B; Viollet B
    Exp Suppl; 2016; 107():327-350. PubMed ID: 27812986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance.
    Garcia D; Shaw RJ
    Mol Cell; 2017 Jun; 66(6):789-800. PubMed ID: 28622524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer.
    Fogarty S; Hardie DG
    Biochim Biophys Acta; 2010 Mar; 1804(3):581-91. PubMed ID: 19778642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural activators of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities.
    Vazirian M; Nabavi SM; Jafari S; Manayi A
    Food Chem Toxicol; 2018 Dec; 122():69-79. PubMed ID: 30290216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct AMP-activated protein kinase activators: a review of evidence from the patent literature.
    Giordanetto F; Karis D
    Expert Opin Ther Pat; 2012 Dec; 22(12):1467-77. PubMed ID: 23136886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK activators--potential therapeutics for metabolic and other diseases.
    Zhou G; Sebhat IK; Zhang BB
    Acta Physiol (Oxf); 2009 May; 196(1):175-90. PubMed ID: 19245659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators.
    Cameron KO; Kurumbail RG
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5139-5148. PubMed ID: 27727125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK activators: mechanisms of action and physiological activities.
    Kim J; Yang G; Kim Y; Kim J; Ha J
    Exp Mol Med; 2016 Apr; 48(4):e224. PubMed ID: 27034026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene of the month. AMP kinase (PRKAA1).
    Krishan S; Richardson DR; Sahni S
    J Clin Pathol; 2014 Sep; 67(9):758-63. PubMed ID: 24895169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer.
    Cao W; Li J; Hao Q; Vadgama JV; Wu Y
    Breast Cancer Res; 2019 Feb; 21(1):29. PubMed ID: 30791936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation.
    Salt IP; Palmer TM
    Expert Opin Investig Drugs; 2012 Aug; 21(8):1155-67. PubMed ID: 22694351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cervical cancer cell growth through activation of upstream kinases of AMP-activated protein kinase.
    Yu SY; Chan DW; Liu VW; Ngan HY
    Tumour Biol; 2009; 30(2):80-5. PubMed ID: 19407487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of allosteric and synergistic activation of AMPK by furan-2-phosphonic derivative C2 binding.
    Langendorf CG; Ngoei KRW; Scott JW; Ling NXY; Issa SMA; Gorman MA; Parker MW; Sakamoto K; Oakhill JS; Kemp BE
    Nat Commun; 2016 Mar; 7():10912. PubMed ID: 26952388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AMP-activated protein kinase (AMPK) as therapeutic target].
    Sarnowska E; Balcerak A; Olszyna-Serementa M; Kotlarek D; Sarnowski TJ; Siedlecki JA
    Postepy Hig Med Dosw (Online); 2013 Aug; 67():750-60. PubMed ID: 24018441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMP-activated protein kinase and cancer.
    Wang W; Guan KL
    Acta Physiol (Oxf); 2009 May; 196(1):55-63. PubMed ID: 19243571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.
    Viollet B; Mounier R; Leclerc J; Yazigi A; Foretz M; Andreelli F
    Diabetes Metab; 2007 Dec; 33(6):395-402. PubMed ID: 17997341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening methods for AMP-activated protein kinase modulators: a patent review.
    Kim J; Shin J; Ha J
    Expert Opin Ther Pat; 2015 Mar; 25(3):261-77. PubMed ID: 25535089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between AMPK and mTOR in regulating energy balance.
    Xu J; Ji J; Yan XH
    Crit Rev Food Sci Nutr; 2012; 52(5):373-81. PubMed ID: 22369257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice.
    Noda K; Nakajima S; Godo S; Saito H; Ikeda S; Shimizu T; Enkhjargal B; Fukumoto Y; Tsukita S; Yamada T; Katagiri H; Shimokawa H
    PLoS One; 2014; 9(11):e110446. PubMed ID: 25365359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.